With the help of high-throughput proteomics and bioinformatics analysis, the Rheb-mTORC1 pathway was predicted to be dysregulated in human breast adenocarcinoma cell line MCF-7 when FADD was knockdown (Figure 2). The gene discussed is RHEB; the disease is breast adenocarcinoma.